{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:16:00Z","timestamp":1790414160656,"version":"4.1.0"},"publisher-location":"Dordrecht","reference-count":158,"publisher":"Springer Netherlands","isbn-type":[{"value":"9789400778924","type":"print"},{"value":"9789400778931","type":"electronic"}],"license":[{"start":{"date-parts":[[2013,12,14]],"date-time":"2013-12-14T00:00:00Z","timestamp":1386979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,12,14]],"date-time":"2013-12-14T00:00:00Z","timestamp":1386979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-94-007-7893-1_8","type":"book-chapter","created":{"date-parts":[[2014,1,17]],"date-time":"2014-01-17T10:51:16Z","timestamp":1389955876000},"page":"107-127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Connective Tissue Disorders and Cardiovascular Complications: The Indomitable Role of Transforming Growth Factor-Beta Signaling"],"prefix":"10.1007","author":[{"given":"Jason B.","family":"Wheeler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Ikonomidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,14]]},"reference":[{"issue":"9501","key":"8_CR1","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(05)67789-6","volume":"366","author":"DP Judge","year":"2005","unstructured":"Judge DP, Dietz HC (2005) Marfan\u2019s syndrome. Lancet 366(9501):1965\u20131976","journal-title":"Lancet"},{"key":"8_CR2","volume-title":"Gene reviews","author":"HC Dietz","year":"1993","unstructured":"Dietz HC (1993) Marfan syndrome. In: Pagon RA (ed) Gene reviews. University of Washington, Seattle"},{"issue":"Pt 1","key":"8_CR3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1242\/jcs.114.1.187","volume":"114","author":"C Unsold","year":"2001","unstructured":"Unsold C et al (2001) Latent TGF-beta binding protein LTBP-1 contains three potential extracellular matrix interacting domains. J Cell Sci 114(Pt 1):187\u2013197","journal-title":"J Cell Sci"},{"issue":"8","key":"8_CR4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/44.8.8756760","volume":"44","author":"J Taipale","year":"1996","unstructured":"Taipale J et al (1996) Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils. J Histochem Cytochem 44(8):875\u2013889","journal-title":"J Histochem Cytochem"},{"issue":"2","key":"8_CR5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1083\/jcb.131.2.539","volume":"131","author":"SL Dallas","year":"1995","unstructured":"Dallas SL et al (1995) Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein. J Cell Biol 131(2):539\u2013549","journal-title":"J Cell Biol"},{"issue":"4","key":"8_CR6","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1074\/jbc.M209256200","volume":"278","author":"Z Isogai","year":"2003","unstructured":"Isogai Z et al (2003) Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J Biol Chem 278(4):2750\u20132757","journal-title":"J Biol Chem"},{"issue":"3","key":"8_CR7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng1116","volume":"33","author":"ER Neptune","year":"2003","unstructured":"Neptune ER et al (2003) Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33(3):407\u2013411","journal-title":"Nat Genet"},{"issue":"3","key":"8_CR8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/ng1511","volume":"37","author":"BL Loeys","year":"2005","unstructured":"Loeys BL et al (2005) A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37(3):275\u2013281","journal-title":"Nat Genet"},{"issue":"6","key":"8_CR9","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/0092-8674(92)90395-S","volume":"71","author":"JL Wrana","year":"1992","unstructured":"Wrana JL et al (1992) TGF beta signals through a heteromeric protein kinase receptor complex. Cell 71(6):1003\u20131014","journal-title":"Cell"},{"issue":"2","key":"8_CR10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0945-053X(03)00002-7","volume":"22","author":"F Ramirez","year":"2003","unstructured":"Ramirez F, Rifkin DB (2003) Cell signaling events: a view from the matrix. Matrix Biol 22(2):101\u2013107","journal-title":"Matrix Biol"},{"issue":"5957","key":"8_CR11","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1126\/science.1176009","volume":"326","author":"RO Hynes","year":"2009","unstructured":"Hynes RO (2009) The extracellular matrix: not just pretty fibrils. Science 326(5957):1216\u20131219","journal-title":"Science"},{"issue":"8","key":"8_CR12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0945-053X(00)00133-5","volume":"19","author":"RA Brekken","year":"2001","unstructured":"Brekken RA, Sage EH (2001) SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol 19(8):816\u2013827","journal-title":"Matrix Biol"},{"issue":"Pt 2","key":"8_CR13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1242\/jcs.00229","volume":"116","author":"JP Annes","year":"2003","unstructured":"Annes JP, Munger JS, Rifkin DB (2003) Making sense of latent TGFbeta activation. J Cell Sci 116(Pt 2):217\u2013224","journal-title":"J Cell Sci"},{"issue":"6488","key":"8_CR14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/370341a0","volume":"370","author":"JL Wrana","year":"1994","unstructured":"Wrana JL et al (1994) Mechanism of activation of the TGF-beta receptor. Nature 370(6488):341\u2013347","journal-title":"Nature"},{"issue":"Pt 24","key":"8_CR15","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1242\/jcs.114.24.4359","volume":"114","author":"A Moustakas","year":"2001","unstructured":"Moustakas A, Souchelnytskyi S, Heldin CH (2001) Smad regulation in TGF-beta signal transduction. J Cell Sci 114(Pt 24):4359\u20134369","journal-title":"J Cell Sci"},{"key":"8_CR16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev.cellbio.21.022404.142018","volume":"21","author":"XH Feng","year":"2005","unstructured":"Feng XH, Derynck R (2005) Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 21:659\u2013693","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"1","key":"8_CR17","first-page":"9","volume":"38","author":"SH Park","year":"2005","unstructured":"Park SH (2005) Fine tuning and cross-talking of TGF-beta signal by inhibitory Smads. J Biochem Mol Biol 38(1):9\u201316","journal-title":"J Biochem Mol Biol"},{"issue":"6651","key":"8_CR18","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/39355","volume":"389","author":"T Imamura","year":"1997","unstructured":"Imamura T et al (1997) Smad6 inhibits signalling by the TGF-beta superfamily. Nature 389(6651):622\u2013626","journal-title":"Nature"},{"issue":"2","key":"8_CR19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1101\/gad.12.2.186","volume":"12","author":"A Hata","year":"1998","unstructured":"Hata A et al (1998) Smad6 inhibits BMP\/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 12(2):186\u2013197","journal-title":"Genes Dev"},{"issue":"Pt 5","key":"8_CR20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1042\/BST0340761","volume":"34","author":"SJ Wicks","year":"2006","unstructured":"Wicks SJ et al (2006) Reversible ubiquitination regulates the Smad\/TGF-beta signalling pathway. Biochem Soc Trans 34(Pt 5):761\u2013763","journal-title":"Biochem Soc Trans"},{"issue":"16","key":"8_CR21","doi-asserted-by":"crossref","first-page":"12477","DOI":"10.1074\/jbc.C100008200","volume":"276","author":"T Ebisawa","year":"2001","unstructured":"Ebisawa T et al (2001) Smurf1 interacts with transforming growth factor-beta type-I receptor through Smad7 and induces receptor degradation. J Biol Chem 276(16):12477\u201312480","journal-title":"J Biol Chem"},{"issue":"6","key":"8_CR22","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S1097-2765(00)00134-9","volume":"6","author":"P Kavsak","year":"2000","unstructured":"Kavsak P et al (2000) Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell 6(6):1365\u20131375","journal-title":"Mol Cell"},{"issue":"6","key":"8_CR23","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.matbio.2006.04.004","volume":"25","author":"R Droguett","year":"2006","unstructured":"Droguett R et al (2006) Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation. Matrix Biol 25(6):332\u2013341","journal-title":"Matrix Biol"},{"issue":"2","key":"8_CR24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s004410051283","volume":"296","author":"M Stander","year":"1999","unstructured":"Stander M et al (1999) Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res 296(2):221\u2013227","journal-title":"Cell Tissue Res"},{"issue":"4","key":"8_CR25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1083\/jcb.124.4.557","volume":"124","author":"F Lopez-Casillas","year":"1994","unstructured":"Lopez-Casillas F et al (1994) Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites. J Cell Biol 124(4):557\u2013568","journal-title":"J Cell Biol"},{"issue":"14","key":"8_CR26","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1093\/emboj\/cdf366","volume":"21","author":"L Yu","year":"2002","unstructured":"Yu L, Hebert MC, Zhang YE (2002) TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J 21(14):3749\u20133759","journal-title":"EMBO J"},{"issue":"5","key":"8_CR27","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1074\/jbc.M204623200","volume":"278","author":"N Dumont","year":"2003","unstructured":"Dumont N, Bakin AV, Arteaga CL (2003) Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells. J Biol Chem 278(5):3275\u20133285","journal-title":"J Biol Chem"},{"issue":"11","key":"8_CR28","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1128\/MCB.18.11.6595","volume":"18","author":"I Griswold-Prenner","year":"1998","unstructured":"Griswold-Prenner I et al (1998) Physical and functional interactions between type-I transforming growth factor beta receptors and Balpha, a WD-40 repeat subunit of phosphatase 2A. Mol Cell Biol 18(11):6595\u20136604","journal-title":"Mol Cell Biol"},{"issue":"6","key":"8_CR29","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1074\/jbc.M208258200","volume":"278","author":"S Itoh","year":"2003","unstructured":"Itoh S et al (2003) Elucidation of Smad requirement in transforming growth factor-beta type-I receptor-induced responses. J Biol Chem 278(6):3751\u20133761","journal-title":"J Biol Chem"},{"issue":"23","key":"8_CR30","doi-asserted-by":"crossref","first-page":"8878","DOI":"10.1128\/MCB.23.23.8878-8889.2003","volume":"23","author":"MC Wilkes","year":"2003","unstructured":"Wilkes MC et al (2003) Cell-type-specific activation of PAK2 by transforming growth factor beta independent of Smad2 and Smad3. Mol Cell Biol 23(23):8878\u20138889","journal-title":"Mol Cell Biol"},{"issue":"47","key":"8_CR31","doi-asserted-by":"crossref","first-page":"31455","DOI":"10.1074\/jbc.273.47.31455","volume":"273","author":"L Choy","year":"1998","unstructured":"Choy L, Derynck R (1998) The type-II transforming growth factor (TGF)-beta receptor-interacting protein TRIP-1 acts as a modulator of the TGF-beta response. J Biol Chem 273(47):31455\u201331462","journal-title":"J Biol Chem"},{"issue":"5715","key":"8_CR32","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1126\/science.1105718","volume":"307","author":"B Ozdamar","year":"2005","unstructured":"Ozdamar B et al (2005) Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 307(5715):1603\u20131609","journal-title":"Science"},{"issue":"5","key":"8_CR33","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/emboj\/18.5.1345","volume":"18","author":"BA Hocevar","year":"1999","unstructured":"Hocevar BA, Brown TL, Howe PH (1999) TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J 18(5):1345\u20131356","journal-title":"EMBO J"},{"issue":"3","key":"8_CR34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1515\/BC.2005.028","volume":"386","author":"Y Imamichi","year":"2005","unstructured":"Imamichi Y et al (2005) TGF beta-induced focal complex formation in epithelial cells is mediated by activated ERK and JNK MAP kinases and is independent of Smad4. Biol Chem 386(3):225\u2013236","journal-title":"Biol Chem"},{"issue":"4","key":"8_CR35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/ncb1113","volume":"6","author":"I Remy","year":"2004","unstructured":"Remy I, Montmarquette A, Michnick SW (2004) PKB\/Akt modulates TGF-beta signalling through a direct interaction with Smad3. Nat Cell Biol 6(4):358\u2013365","journal-title":"Nat Cell Biol"},{"issue":"4","key":"8_CR36","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1074\/jbc.M310412200","volume":"279","author":"CE Runyan","year":"2004","unstructured":"Runyan CE, Schnaper HW, Poncelet AC (2004) The phosphatidylinositol 3-kinase\/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1. J Biol Chem 279(4):2632\u20132639","journal-title":"J Biol Chem"},{"issue":"3","key":"8_CR37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1096\/fj.00-0474fje","volume":"15","author":"I Yakymovych","year":"2001","unstructured":"Yakymovych I et al (2001) Regulation of Smad signaling by protein kinase C. FASEB J 15(3):553\u2013555","journal-title":"FASEB J"},{"issue":"9","key":"8_CR38","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1074\/jbc.M806962200","volume":"284","author":"L Carta","year":"2009","unstructured":"Carta L et al (2009) p38 MAPK is an early determinant of promiscuous Smad2\/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice. J Biol Chem 284(9):5630\u20135636","journal-title":"J Biol Chem"},{"issue":"6","key":"8_CR39","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.molcel.2008.09.002","volume":"31","author":"M Yamashita","year":"2008","unstructured":"Yamashita M et al (2008) TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol Cell 31(6):918\u2013924","journal-title":"Mol Cell"},{"issue":"10","key":"8_CR40","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/ncb1780","volume":"10","author":"A Sorrentino","year":"2008","unstructured":"Sorrentino A et al (2008) The type-I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol 10(10):1199\u20131207","journal-title":"Nat Cell Biol"},{"issue":"17","key":"8_CR41","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1038\/sj.emboj.7601818","volume":"26","author":"MK Lee","year":"2007","unstructured":"Lee MK et al (2007) TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J 26(17):3957\u20133967","journal-title":"EMBO J"},{"issue":"22","key":"8_CR42","doi-asserted-by":"crossref","first-page":"10431","DOI":"10.1158\/0008-5472.CAN-05-1522","volume":"65","author":"MC Wilkes","year":"2005","unstructured":"Wilkes MC et al (2005) Transforming growth factor-beta activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2. Cancer Res 65(22):10431\u201310440","journal-title":"Cancer Res"},{"issue":"6 Suppl","key":"8_CR43","doi-asserted-by":"crossref","first-page":"585S","DOI":"10.1378\/chest.128.6_suppl.585S","volume":"128","author":"P Bertolino","year":"2005","unstructured":"Bertolino P et al (2005) Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders. Chest 128(6 Suppl):585S\u2013590S","journal-title":"Chest"},{"issue":"3","key":"8_CR44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/35043051","volume":"1","author":"J Massague","year":"2000","unstructured":"Massague J (2000) How cells read TGF-beta signals. Nat Rev Mol Cell Biol 1(3):169\u2013178","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"8_CR45","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1016\/S0021-9258(17)35666-1","volume":"261","author":"RA Ignotz","year":"1986","unstructured":"Ignotz RA, Massague J (1986) Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261(9):4337\u20134345","journal-title":"J Biol Chem"},{"issue":"1","key":"8_CR46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jcp.20948","volume":"211","author":"C Yan","year":"2007","unstructured":"Yan C, Boyd DD (2007) Regulation of matrix metalloproteinase gene expression. J Cell Physiol 211(1):19\u201326","journal-title":"J Cell Physiol"},{"issue":"3","key":"8_CR47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1158\/1541-7786.MCR-05-0140","volume":"4","author":"HJ Kwak","year":"2006","unstructured":"Kwak HJ et al (2006) Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells. Mol Cancer Res MCR 4(3):209\u2013220","journal-title":"Mol Cancer Res MCR"},{"issue":"5","key":"8_CR48","first-page":"1375","volume":"25","author":"ES Kim","year":"2004","unstructured":"Kim ES, Kim MS, Moon A (2004) TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int J Oncol 25(5):1375\u20131382","journal-title":"Int J Oncol"},{"issue":"2","key":"8_CR49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0014-4827(86)90038-8","volume":"164","author":"M Laiho","year":"1986","unstructured":"Laiho M, Saksela O, Keski-Oja J (1986) Transforming growth factor beta alters plasminogen activator activity in human skin fibroblasts. Exp Cell Res 164(2):399\u2013407","journal-title":"Exp Cell Res"},{"issue":"2","key":"8_CR50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000151766","volume":"46","author":"JA Jones","year":"2009","unstructured":"Jones JA, Spinale FG, Ikonomidis JS (2009) Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis. J Vasc Res 46(2):119\u2013137","journal-title":"J Vasc Res"},{"issue":"18","key":"8_CR51","doi-asserted-by":"crossref","first-page":"19327","DOI":"10.1074\/jbc.M314048200","volume":"279","author":"N Selvamurugan","year":"2004","unstructured":"Selvamurugan N et al (2004) Transforming growth factor-beta 1 regulation of collagenase-3 expression in osteoblastic cells by cross-talk between the Smad and MAPK signaling pathways and their components, Smad2 and Runx2. J Biol Chem 279(18):19327\u201319334","journal-title":"J Biol Chem"},{"key":"8_CR52","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1750-1172-6-80","volume":"6","author":"RJ Pignolo","year":"2011","unstructured":"Pignolo RJ, Shore EM, Kaplan FS (2011) Fibrodysplasia ossificans progressiva: clinical and genetic aspects. Orphanet J Rare Dis 6:80","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"8_CR53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cytogfr.2006.01.001","volume":"17","author":"S Werner","year":"2006","unstructured":"Werner S, Alzheimer C (2006) Roles of activin in tissue repair, fibrosis, and inflammatory disease. Cytokine Growth Factor Rev 17(3):157\u2013171","journal-title":"Cytokine Growth Factor Rev"},{"key":"8_CR54","volume-title":"Gene reviews","author":"DM Milewicz","year":"1993","unstructured":"Milewicz DM, Regalado E (1993) Thoracic aortic aneurysms and aortic dissections. In: Pagon RA (ed) Gene reviews. University of Washington, Seattle"},{"issue":"25","key":"8_CR55","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1161\/CIRCULATIONAHA.109.887042","volume":"120","author":"D Attias","year":"2009","unstructured":"Attias D et al (2009) Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation 120(25):2541\u20132549","journal-title":"Circulation"},{"issue":"2","key":"8_CR56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.amjmed.2003.08.030","volume":"116","author":"Y von Kodolitsch","year":"2004","unstructured":"von Kodolitsch Y et al (2004) Chest radiography for the diagnosis of acute aortic syndrome. Am J Med 116(2):73\u201377","journal-title":"Am J Med"},{"issue":"2","key":"8_CR57","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/hrt.51.2.220","volume":"51","author":"L Bruno","year":"1984","unstructured":"Bruno L et al (1984) Cardiac, skeletal, and ocular abnormalities in patients with Marfan\u2019s syndrome and in their relatives. Comparison with the cardiac abnormalities in patients with kyphoscoliosis. Br Heart J 51(2):220\u2013230","journal-title":"Br Heart J"},{"issue":"1","key":"8_CR58","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ajmg.c.30069","volume":"139C","author":"H Pannu","year":"2005","unstructured":"Pannu H, Tran-Fadulu V, Milewicz DM (2005) Genetic basis of thoracic aortic aneurysms and aortic dissections. Am J Med Genet C Semin Med Genet 139C(1):10\u201316","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"8","key":"8_CR59","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1056\/NEJMoa055695","volume":"355","author":"BL Loeys","year":"2006","unstructured":"Loeys BL et al (2006) Aneurysm syndromes caused by mutations in the TGF-beta receptor. New Engl J Med 355(8):788\u2013798","journal-title":"New Engl J Med"},{"issue":"3","key":"8_CR60","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0741-5214(97)70261-1","volume":"25","author":"A Biddinger","year":"1997","unstructured":"Biddinger A et al (1997) Familial thoracic aortic dilatations and dissections: a case control study. J Vasc Surg 25(3):506\u2013511","journal-title":"J Vasc Surg"},{"issue":"7","key":"8_CR61","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jama.283.7.897","volume":"283","author":"PG Hagan","year":"2000","unstructured":"Hagan PG et al (2000) The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 283(7):897\u2013903","journal-title":"JAMA"},{"issue":"5","key":"8_CR62","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ajhg.2009.04.007","volume":"84","author":"DC Guo","year":"2009","unstructured":"Guo DC et al (2009) Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet 84(5):617\u2013627","journal-title":"Am J Hum Genet"},{"issue":"10","key":"8_CR63","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/ajmg.a.33657","volume":"152A","author":"DM Milewicz","year":"2010","unstructured":"Milewicz DM et al (2010) De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction. Am J Med Genet A 152A(10):2437\u20132443","journal-title":"Am J Med Genet A"},{"issue":"17","key":"8_CR64","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/ajmg.a.31872","volume":"143A","author":"ML Loscalzo","year":"2007","unstructured":"Loscalzo ML et al (2007) Familial thoracic aortic dilation and bicommissural aortic valve: a prospective analysis of natural history and inheritance. Am J Med Genet A 143A(17):1960\u20131967","journal-title":"Am J Med Genet A"},{"issue":"3","key":"8_CR65","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ng1721","volume":"38","author":"L Zhu","year":"2006","unstructured":"Zhu L et al (2006) Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm\/aortic dissection and patent ductus arteriosus. Nat Genet 38(3):343\u2013349","journal-title":"Nat Genet"},{"issue":"6","key":"8_CR66","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.CIR.0000154569.08857.7A","volume":"111","author":"EM Isselbacher","year":"2005","unstructured":"Isselbacher EM (2005) Thoracic and abdominal aortic aneurysms. Circulation 111(6):816\u2013828","journal-title":"Circulation"},{"issue":"27","key":"8_CR67","doi-asserted-by":"crossref","first-page":"25109","DOI":"10.1074\/jbc.M300636200","volume":"278","author":"CP Denton","year":"2003","unstructured":"Denton CP et al (2003) Fibroblast-specific expression of a kinase-deficient type-II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic mice. J Biol Chem 278(27):25109\u201325119","journal-title":"J Biol Chem"},{"issue":"17","key":"8_CR68","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1046\/j.1432-1327.2000.01621.x","volume":"267","author":"SH Wong","year":"2000","unstructured":"Wong SH et al (2000) Endoglin expression on human microvascular endothelial cells association with betaglycan and formation of higher order complexes with TGF-beta signalling receptors. Eur J Biochem\/FEBS 267(17):5550\u20135560","journal-title":"Eur J Biochem\/FEBS"},{"issue":"5","key":"8_CR69","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ncb975","volume":"5","author":"GM Di Guglielmo","year":"2003","unstructured":"Di Guglielmo GM et al (2003) Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Biol 5(5):410\u2013421","journal-title":"Nat Cell Biol"},{"issue":"6651","key":"8_CR70","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/39369","volume":"389","author":"A Nakao","year":"1997","unstructured":"Nakao A et al (1997) Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389(6651):631\u2013635","journal-title":"Nature"},{"issue":"2","key":"8_CR71","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ng.744","volume":"43","author":"IM van de Laar","year":"2011","unstructured":"van de Laar IM et al (2011) Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet 43(2):121\u2013126","journal-title":"Nat Genet"},{"issue":"2","key":"8_CR72","first-page":"69","volume":"70","author":"B Loeys","year":"2008","unstructured":"Loeys B, De Paepe A (2008) New insights in the pathogenesis of aortic aneurysms. Verh K Acad Geneeskd Belg 70(2):69\u201384","journal-title":"Verh K Acad Geneeskd Belg"},{"issue":"4","key":"8_CR73","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/ng1764","volume":"38","author":"PJ Coucke","year":"2006","unstructured":"Coucke PJ et al (2006) Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat Genet 38(4):452\u2013457","journal-title":"Nat Genet"},{"issue":"1","key":"8_CR74","first-page":"65","volume":"2","author":"RJ Shprintzen","year":"1982","unstructured":"Shprintzen RJ, Goldberg RB (1982) A recurrent pattern syndrome of craniosynostosis associated with arachnodactyly and abdominal hernias. J Craniofac Genet Dev Biol 2(1):65\u201374","journal-title":"J Craniofac Genet Dev Biol"},{"issue":"3","key":"8_CR75","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/(SICI)1096-8628(19980319)76:3<202::AID-AJMG2>3.0.CO;2-S","volume":"76","author":"MT Greally","year":"1998","unstructured":"Greally MT et al (1998) Shprintzen-Goldberg syndrome: a clinical analysis. Am J Med Genet 76(3):202\u2013212","journal-title":"Am J Med Genet"},{"issue":"8","key":"8_CR76","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1253\/circj.71.1305","volume":"71","author":"K Akutsu","year":"2007","unstructured":"Akutsu K et al (2007) Phenotypic heterogeneity of Marfan-like connective tissue disorders associated with mutations in the transforming growth factor-beta receptor genes. Circ J 71(8):1305\u20131309","journal-title":"Circ J"},{"key":"8_CR77","volume-title":"Gene reviews","author":"MT Greally","year":"1993","unstructured":"Greally MT (1993) Shprintzen-Goldberg syndrome. In: Pagon RA et al (eds) Gene reviews. University of Washington, Seattle"},{"issue":"3","key":"8_CR78","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ajmg.a.30431","volume":"135","author":"PN Robinson","year":"2005","unstructured":"Robinson PN et al (2005) Shprintzen-Goldberg syndrome: fourteen new patients and a clinical analysis. Am J Med Genet A 135(3):251\u2013262","journal-title":"Am J Med Genet A"},{"issue":"4","key":"8_CR79","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ajmg.1320570410","volume":"57","author":"LC Ades","year":"1995","unstructured":"Ades LC et al (1995) Distinct skeletal abnormalities in four girls with Shprintzen-Goldberg syndrome. Am J Med Genet 57(4):565\u2013572","journal-title":"Am J Med Genet"},{"issue":"10","key":"8_CR80","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ajmg.a.31202","volume":"140","author":"LC Ades","year":"2006","unstructured":"Ades LC et al (2006) FBN1, TGFBR1, and the Marfan-craniosynostosis\/mental retardation disorders revisited. Am J Med Genet A 140(10):1047\u20131058","journal-title":"Am J Med Genet A"},{"issue":"11","key":"8_CR81","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1172\/JCI200422715","volume":"114","author":"CM Ng","year":"2004","unstructured":"Ng CM (2004) TGF- -dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 114(11):1586\u20131592","journal-title":"J Clin Invest"},{"issue":"5","key":"8_CR82","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/j.athoracsur.2010.12.060","volume":"91","author":"E Girdauskas","year":"2011","unstructured":"Girdauskas E et al (2011) Transforming growth factor-beta receptor type-II mutation in a patient with bicuspid aortic valve disease and intraoperative aortic dissection. Ann Thorac Surg 91(5):e70\u2013e71","journal-title":"Ann Thorac Surg"},{"key":"8_CR83","first-page":"1322","volume":"135","author":"H Rendu","year":"1896","unstructured":"Rendu H (1896) Epistaxis repetees chez un sujet porteur de petits angiomes cutanes et muquez. Gazette des Hopitaux Civils et Militaires (Paris) 135:1322","journal-title":"Gazette des Hopitaux Civils et Militaires (Paris)"},{"key":"8_CR84","first-page":"333","volume":"12","author":"W Osler","year":"1901","unstructured":"Osler W (1901) On a family form of recurring epistaxis, associated with multiple telangectases of the skin and mucous membranes. Bull Johns Hopkins Hosp 12:333","journal-title":"Bull Johns Hopkins Hosp"},{"key":"8_CR85","first-page":"160","volume":"2","author":"F Weber","year":"1907","unstructured":"Weber F (1907) Multiple hereditary developmental angiomata (telangiectases) of the skin and mucous membranes associated with recurring hemorrhages. Lancet 2:160\u2013162","journal-title":"Lancet"},{"issue":"1","key":"8_CR86","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2796.1999.00398.x","volume":"245","author":"AD Kjeldsen","year":"1999","unstructured":"Kjeldsen AD, Vase P, Green A (1999) Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med 245(1):31\u201339","journal-title":"J Intern Med"},{"issue":"1","key":"8_CR87","first-page":"3","volume":"44","author":"A Bideau","year":"1989","unstructured":"Bideau A et al (1989) Epidemiological investigation of Rendu-Osler disease in France: its geographical distribution and prevalence. Popul Engl Sel 44(1):3\u201322","journal-title":"Popul Engl Sel"},{"issue":"3","key":"8_CR88","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/thx.2007.087452","volume":"63","author":"CL Shovlin","year":"2008","unstructured":"Shovlin CL et al (2008) Primary determinants of ischaemic stroke\/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax 63(3):259\u2013266","journal-title":"Thorax"},{"issue":"10","key":"8_CR89","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI8088","volume":"104","author":"A Bourdeau","year":"1999","unstructured":"Bourdeau A, Dumont DJ, Letarte M (1999) A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 104(10):1343\u20131351","journal-title":"J Clin Invest"},{"issue":"8","key":"8_CR90","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/thorax.55.8.685","volume":"55","author":"GM Wallace","year":"2000","unstructured":"Wallace GM, Shovlin CL (2000) A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1. Thorax 55(8):685\u2013690","journal-title":"Thorax"},{"issue":"7","key":"8_CR91","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/jmg.2004.028712","volume":"42","author":"SG Cole","year":"2005","unstructured":"Cole SG et al (2005) A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet 42(7):577\u2013582","journal-title":"J Med Genet"},{"issue":"3","key":"8_CR92","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ajmg.1320320302","volume":"32","author":"H Plauchu","year":"1989","unstructured":"Plauchu H et al (1989) Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 32(3):291\u2013297","journal-title":"Am J Med Genet"},{"issue":"10","key":"8_CR93","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/qjmed\/hci115","volume":"98","author":"G Pasculli","year":"2005","unstructured":"Pasculli G et al (2005) Capillaroscopy of the dorsal skin of the hands in hereditary hemorrhagic telangiectasia. QJM 98(10):757\u2013763","journal-title":"QJM"},{"issue":"3","key":"8_CR94","first-page":"477","volume":"19","author":"RK Fulbright","year":"1998","unstructured":"Fulbright RK et al (1998) MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. AJNR Am J Neuroradiol 19(3):477\u2013484","journal-title":"AJNR Am J Neuroradiol"},{"issue":"9","key":"8_CR95","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1164\/rccm.200310-1441OC","volume":"169","author":"V Cottin","year":"2004","unstructured":"Cottin V et al (2004) Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. Am J Respir Crit Care Med 169(9):994\u20131000","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"8_CR96","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/jmg.33.6.441","volume":"33","author":"M Piantanida","year":"1996","unstructured":"Piantanida M et al (1996) Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2. J Med Genet 33(6):441\u2013443","journal-title":"J Med Genet"},{"issue":"7","key":"8_CR97","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ejhg.2009.35","volume":"17","author":"FS Govani","year":"2009","unstructured":"Govani FS, Shovlin CL (2009) Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet 17(7):860\u2013871","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"8_CR98","first-page":"1031","volume":"98","author":"CL Shovlin","year":"2007","unstructured":"Shovlin CL et al (2007) Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism. Thromb Haemost 98(5):1031\u20131039","journal-title":"Thromb Haemost"},{"issue":"10","key":"8_CR99","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.2174\/138161206776361336","volume":"12","author":"A Cirulli","year":"2006","unstructured":"Cirulli A et al (2006) Patients with Hereditary Hemorrhagic Telangectasia (HHT) exhibit a deficit of polymorphonuclear cell and monocyte oxidative burst and phagocytosis: a possible correlation with altered adaptive immune responsiveness in HHT. Curr Pharm Des 12(10):1209\u20131215","journal-title":"Curr Pharm Des"},{"issue":"1","key":"8_CR100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","volume":"91","author":"CL Shovlin","year":"2000","unstructured":"Shovlin CL et al (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91(1):66\u201367","journal-title":"Am J Med Genet"},{"issue":"2","key":"8_CR101","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jmg.2009.069013","volume":"48","author":"ME Faughnan","year":"2011","unstructured":"Faughnan ME et al (2011) International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 48(2):73\u201387","journal-title":"J Med Genet"},{"issue":"4","key":"8_CR102","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng1294-345","volume":"8","author":"KA McAllister","year":"1994","unstructured":"McAllister KA et al (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8(4):345\u2013351","journal-title":"Nat Genet"},{"issue":"1","key":"8_CR103","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/513903","volume":"61","author":"JN Berg","year":"1997","unstructured":"Berg JN et al (1997) The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am J Hum Genet 61(1):60\u201367","journal-title":"Am J Hum Genet"},{"issue":"2","key":"8_CR104","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng0696-189","volume":"13","author":"DW Johnson","year":"1996","unstructured":"Johnson DW et al (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13(2):189\u2013195","journal-title":"Nat Genet"},{"issue":"5","key":"8_CR105","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/ajmg.a.33968","volume":"155A","author":"S Andrabi","year":"2011","unstructured":"Andrabi S et al (2011) SMAD4 mutation segregating in a family with juvenile polyposis, aortopathy, and mitral valve dysfunction. Am J Med Genet A 155A(5):1165\u20131169","journal-title":"Am J Med Genet A"},{"issue":"1","key":"8_CR106","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cardiores.2005.04.028","volume":"68","author":"M Letarte","year":"2005","unstructured":"Letarte M et al (2005) Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1. Cardiovasc Res 68(1):155\u2013164","journal-title":"Cardiovasc Res"},{"issue":"12","key":"8_CR107","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1242\/dev.129.12.3009","volume":"129","author":"BL Roman","year":"2002","unstructured":"Roman BL et al (2002) Disruption of acvrl1 increases endothelial cell number in zebrafish cranial vessels. Development 129(12):3009\u20133019","journal-title":"Development"},{"issue":"6","key":"8_CR108","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1073\/pnas.97.6.2626","volume":"97","author":"SP Oh","year":"2000","unstructured":"Oh SP et al (2000) Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A 97(6):2626\u20132631","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"8_CR109","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/01.RES.0000095246.40391.3B","volume":"93","author":"T Seki","year":"2003","unstructured":"Seki T, Yun J, Oh SP (2003) Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res 93(7):682\u2013689","journal-title":"Circ Res"},{"issue":"11","key":"8_CR110","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.1074\/jbc.M007609200","volume":"276","author":"S Stefansson","year":"2001","unstructured":"Stefansson S et al (2001) Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1. J Biol Chem 276(11):8135\u20138141","journal-title":"J Biol Chem"},{"issue":"2","key":"8_CR111","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cardiores.2005.06.009","volume":"68","author":"LA Fernandez","year":"2005","unstructured":"Fernandez LA et al (2005) Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions. Cardiovasc Res 68(2):235\u2013248","journal-title":"Cardiovasc Res"},{"issue":"4","key":"8_CR112","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1097-2765(03)00386-1","volume":"12","author":"MJ Goumans","year":"2003","unstructured":"Goumans MJ et al (2003) Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta\/ALK-5 signaling. Mol Cell 12(4):817\u2013828","journal-title":"Mol Cell"},{"issue":"6","key":"8_CR113","doi-asserted-by":"crossref","first-page":"L604","DOI":"10.1152\/ajplung.00309.2011","volume":"302","author":"RJ Davies","year":"2012","unstructured":"Davies RJ et al (2012) BMP type-II receptor deficiency confers resistance to growth inhibition by TGF-beta in pulmonary artery smooth muscle cells: role of proinflammatory cytokines. Am J Physiol Lung Cell Mol Physiol 302(6):L604\u2013L615","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"8","key":"8_CR114","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/01.RES.0000126047.82846.20","volume":"94","author":"J West","year":"2004","unstructured":"West J et al (2004) Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle. Circ Res 94(8):1109\u20131114","journal-title":"Circ Res"},{"issue":"23","key":"8_CR115","doi-asserted-by":"crossref","first-page":"17647","DOI":"10.1074\/jbc.M908622199","volume":"275","author":"N Kimura","year":"2000","unstructured":"Kimura N et al (2000) BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. J Biol Chem 275(23):17647\u201317652","journal-title":"J Biol Chem"},{"issue":"5","key":"8_CR116","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJM200108023450503","volume":"345","author":"RC Trembath","year":"2001","unstructured":"Trembath RC et al (2001) Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. New Engl J Med 345(5):325\u2013334","journal-title":"New Engl J Med"},{"issue":"12","key":"8_CR117","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1093\/carcin\/bgm195","volume":"28","author":"HJ You","year":"2007","unstructured":"You HJ et al (2007) The type-III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation. Carcinogenesis 28(12):2491\u20132500","journal-title":"Carcinogenesis"},{"issue":"4","key":"8_CR118","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/08977194.2011.595411","volume":"29","author":"LJ Hawinkels","year":"2011","unstructured":"Hawinkels LJ, Ten Dijke P (2011) Exploring anti-TGF-beta therapies in cancer and fibrosis. Growth Factors 29(4):140\u2013152","journal-title":"Growth Factors"},{"issue":"2","key":"8_CR119","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.trsl.2008.06.002","volume":"152","author":"MC Rico","year":"2008","unstructured":"Rico MC et al (2008) Thrombospondin-1 and transforming growth factor beta are pro-inflammatory molecules in rheumatoid arthritis. Transl Res 152(2):95\u201398","journal-title":"Transl Res"},{"issue":"3","key":"8_CR120","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/157016110791112296","volume":"8","author":"MC Rico","year":"2010","unstructured":"Rico MC et al (2010) The axis of thrombospondin-1, transforming growth factor beta and connective tissue growth factor: an emerging therapeutic target in rheumatoid arthritis. Curr Vasc Pharmacol 8(3):338\u2013343","journal-title":"Curr Vasc Pharmacol"},{"issue":"2","key":"8_CR121","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/ar1504","volume":"7","author":"SM Wahl","year":"2005","unstructured":"Wahl SM, Chen W (2005) Transforming growth factor-beta-induced regulatory T cells referee inflammatory and autoimmune diseases. Arthritis Res Ther 7(2):62\u201368","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"8_CR122","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.4049\/jimmunol.160.5.2539","volume":"160","author":"K Ohtsuka","year":"1998","unstructured":"Ohtsuka K et al (1998) Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus. J Immunol 160(5):2539\u20132545","journal-title":"J Immunol"},{"issue":"10","key":"8_CR123","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/sj.gt.3302016","volume":"10","author":"RA Mageed","year":"2003","unstructured":"Mageed RA, Prud\u2019homme GJ (2003) Immunopathology and the gene therapy of lupus. Gene Ther 10(10):861\u2013874","journal-title":"Gene Ther"},{"issue":"13","key":"8_CR124","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1161\/CIR.0b013e3181d47d48","volume":"121","author":"LF Hiratzka","year":"2010","unstructured":"Hiratzka LF et al (2010) ACCF\/AHA\/AATS\/ACR\/ASA\/SCA\/SCAI\/SIR\/STS\/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 121(13):e266\u2013e369","journal-title":"Circulation"},{"issue":"4","key":"8_CR125","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0733-8651(05)70118-1","volume":"17","author":"MA Coady","year":"1999","unstructured":"Coady MA, Rizzo JA, Elefteriades JA (1999) Developing surgical intervention criteria for thoracic aortic aneurysms. Cardiol Clin 17(4):827\u2013839","journal-title":"Cardiol Clin"},{"issue":"6","key":"8_CR126","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/S0003-4975(99)00431-2","volume":"67","author":"MA Coady","year":"1999","unstructured":"Coady MA et al (1999) Surgical intervention criteria for thoracic aortic aneurysms: a study of growth rates and complications. Ann Thorac Surg 67(6):1922\u20131926, discussion 1953\u20131958","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"8_CR127","doi-asserted-by":"crossref","first-page":"S1877","DOI":"10.1016\/S0003-4975(02)04147-4","volume":"74","author":"JA Elefteriades","year":"2002","unstructured":"Elefteriades JA (2002) Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. Ann Thorac Surg 74(5):S1877\u2013S1880, discussion S1892\u2013S1898","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"8_CR128","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0741-5214(98)70319-2","volume":"27","author":"AC Lobato","year":"1998","unstructured":"Lobato AC, Puech-Leao P (1998) Predictive factors for rupture of thoracoabdominal aortic aneurysm. J Vasc Surg 27(3):446\u2013453","journal-title":"J Vasc Surg"},{"issue":"3","key":"8_CR129","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0741-5214(89)90435-7","volume":"10","author":"LG Svensson","year":"1989","unstructured":"Svensson LG et al (1989) Appraisal of adjuncts to prevent acute renal failure after surgery on the thoracic or thoracoabdominal aorta. J Vasc Surg 10(3):230\u2013239","journal-title":"J Vasc Surg"},{"issue":"2","key":"8_CR130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0741-5214(93)90421-H","volume":"17","author":"LG Svensson","year":"1993","unstructured":"Svensson LG et al (1993) Experience with 1509 patients undergoing thoracoabdominal aortic operations. J Vasc Surg 17(2):357\u2013368, discussion 368\u2013370","journal-title":"J Vasc Surg"},{"issue":"8","key":"8_CR131","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/01.ATV.0000225287.20034.2c","volume":"26","author":"A Bobik","year":"2006","unstructured":"Bobik A (2006) Transforming growth factor-betas and vascular disorders. Arterioscler Thromb Vasc Biol 26(8):1712\u20131720","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1 Suppl","key":"8_CR132","first-page":"I365","volume":"114","author":"JS Ikonomidis","year":"2006","unstructured":"Ikonomidis JS et al (2006) Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome. Circulation 114(1 Suppl):I365\u2013I370","journal-title":"Circulation"},{"issue":"2","key":"8_CR133","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1124\/mol.105.021600","volume":"70","author":"AM Kapoun","year":"2006","unstructured":"Kapoun AM et al (2006) Transforming growth factor-beta receptor type 1 (TGFbetaRI) kinase activity but not p38 activation is required for TGFbetaRI-induced myofibroblast differentiation and profibrotic gene expression. Mol Pharmacol 70(2):518\u2013531","journal-title":"Mol Pharmacol"},{"issue":"1","key":"8_CR134","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00408-005-2560-5","volume":"184","author":"Y Hu","year":"2006","unstructured":"Hu Y et al (2006) Role of extracellular signal-regulated kinase, p38 kinase, and activator protein-1 in transforming growth factor-beta1-induced alpha smooth muscle actin expression in human fetal lung fibroblasts in vitro. Lung 184(1):33\u201342","journal-title":"Lung"},{"issue":"8","key":"8_CR135","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/CIRCULATIONAHA.108.769695","volume":"118","author":"RK Greenberg","year":"2008","unstructured":"Greenberg RK et al (2008) Contemporary analysis of descending thoracic and thoracoabdominal aneurysm repair: a comparison of endovascular and open techniques. Circulation 118(8):808\u2013817","journal-title":"Circulation"},{"issue":"5","key":"8_CR136","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jvs.2007.12.006","volume":"47","author":"MS Makaroun","year":"2008","unstructured":"Makaroun MS et al (2008) Five-year results of endovascular treatment with the Gore TAG device compared with open repair of thoracic aortic aneurysms. J Vasc Surg 47(5):912\u2013918","journal-title":"J Vasc Surg"},{"issue":"9","key":"8_CR137","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.amjcard.2005.01.032","volume":"95","author":"AT Yetman","year":"2005","unstructured":"Yetman AT, Bornemeier RA, McCrindle BW (2005) Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome. Am J Cardiol 95(9):1125\u20131127","journal-title":"Am J Cardiol"},{"issue":"10","key":"8_CR138","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0895-7061(00)00298-3","volume":"13","author":"A Kubo","year":"2000","unstructured":"Kubo A et al (2000) Angiotensin II regulates the cell cycle of vascular smooth muscle cells from SHR. Am J Hypertens 13(10):1117\u20131124","journal-title":"Am J Hypertens"},{"issue":"5770","key":"8_CR139","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","volume":"312","author":"JP Habashi","year":"2006","unstructured":"Habashi JP et al (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312(5770):117\u2013121","journal-title":"Science"},{"issue":"6027","key":"8_CR140","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1126\/science.1192152","volume":"332","author":"JP Habashi","year":"2011","unstructured":"Habashi JP et al (2011) Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 332(6027):361\u2013365","journal-title":"Science"},{"issue":"6","key":"8_CR141","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12265-011-9314-y","volume":"4","author":"DP Judge","year":"2011","unstructured":"Judge DP et al (2011) Mitral valve disease in Marfan syndrome and related disorders. J Cardiovasc Transl Res 4(6):741\u2013747","journal-title":"J Cardiovasc Transl Res"},{"issue":"6027","key":"8_CR142","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.1192149","volume":"332","author":"TM Holm","year":"2011","unstructured":"Holm TM et al (2011) Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 332(6027):358\u2013361","journal-title":"Science"},{"issue":"2","key":"8_CR143","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ccl.2010.01.017","volume":"28","author":"DM Milewicz","year":"2010","unstructured":"Milewicz DM, Carlson AA, Regalado ES (2010) Genetic testing in aortic aneurysm disease: PRO. Cardiol Clin 28(2):191\u2013197","journal-title":"Cardiol Clin"},{"issue":"2","key":"8_CR144","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ng0296-209","volume":"12","author":"S Sood","year":"1996","unstructured":"Sood S et al (1996) Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome. Nat Genet 12(2):209\u2013211","journal-title":"Nat Genet"},{"issue":"1","key":"8_CR145","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ajmg.a.31006","volume":"140","author":"K Kosaki","year":"2006","unstructured":"Kosaki K et al (2006) Molecular pathology of Shprintzen-Goldberg syndrome. Am J Med Genet A 140(1):104\u2013108, author reply 109\u2013110","journal-title":"Am J Med Genet A"},{"issue":"4","key":"8_CR146","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1600-0625.2007.00648.x","volume":"17","author":"MA van Steensel","year":"2008","unstructured":"van Steensel MA et al (2008) Shprintzen-Goldberg syndrome associated with a novel missense mutation in TGFBR2. Exp Dermatol 17(4):362\u2013365","journal-title":"Exp Dermatol"},{"issue":"11","key":"8_CR147","doi-asserted-by":"crossref","first-page":"E284","DOI":"10.1002\/humu.20871","volume":"29","author":"C Stheneur","year":"2008","unstructured":"Stheneur C et al (2008) Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype-Investigations in 457 patients with Marfan syndrome type-I and II, Loeys-Dietz syndrome and related disorders. Hum Mutat 29(11):E284\u2013E295","journal-title":"Hum Mutat"},{"issue":"5","key":"8_CR148","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/194589240501900515","volume":"19","author":"TS Kuhnel","year":"2005","unstructured":"Kuhnel TS et al (2005) Clinical strategy in hereditary hemorrhagic telangiectasia. Am J Rhinol 19(5):508\u2013513","journal-title":"Am J Rhinol"},{"issue":"9","key":"8_CR149","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1478-3231.2006.01340.x","volume":"26","author":"E Buscarini","year":"2006","unstructured":"Buscarini E et al (2006) Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations. Liver Int 26(9):1040\u20131046","journal-title":"Liver Int"},{"issue":"2","key":"8_CR150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ajmg.a.30838","volume":"137","author":"JH Cohen","year":"2005","unstructured":"Cohen JH et al (2005) Cost comparison of genetic and clinical screening in families with hereditary hemorrhagic telangiectasia. Am J Med Genet A 137(2):153\u2013160","journal-title":"Am J Med Genet A"},{"issue":"2","key":"8_CR151","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/jmg.2005.030833","volume":"43","author":"SA Abdalla","year":"2006","unstructured":"Abdalla SA, Letarte M (2006) Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet 43(2):97\u2013110","journal-title":"J Med Genet"},{"issue":"6","key":"8_CR152","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1083\/jcb.201008116","volume":"190","author":"DB Rifkin","year":"2010","unstructured":"Rifkin DB, Todorovic V (2010) Bone matrix to growth factors: location, location, location. J Cell Biol 190(6):949\u2013951","journal-title":"J Cell Biol"},{"issue":"49","key":"8_CR153","doi-asserted-by":"crossref","first-page":"34229","DOI":"10.1074\/jbc.M803142200","volume":"283","author":"P Atsawasuwan","year":"2008","unstructured":"Atsawasuwan P et al (2008) Lysyl oxidase binds transforming growth factor-beta and regulates its signaling via amine oxidase activity. J Biol Chem 283(49):34229\u201334240","journal-title":"J Biol Chem"},{"issue":"1","key":"8_CR154","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3121\/cmr.4.1.66","volume":"4","author":"LA Fernandez","year":"2006","unstructured":"Fernandez LA et al (2006) Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway. Clin Med Res 4(1):66\u201378","journal-title":"Clin Med Res"},{"issue":"3","key":"8_CR155","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1053\/j.semtcvs.2005.06.001","volume":"17","author":"TG Gleason","year":"2005","unstructured":"Gleason TG (2005) Heritable disorders predisposing to aortic dissection. Semin Thorac Cardiovasc Surg 17(3):274\u2013281","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"4","key":"8_CR156","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/CIRCULATIONAHA.105.537340","volume":"112","author":"H Pannu","year":"2005","unstructured":"Pannu H et al (2005) Mutations in transforming growth factor-beta receptor type-II cause familial thoracic aortic aneurysms and dissections. Circulation 112(4):513\u2013520","journal-title":"Circulation"},{"issue":"1","key":"8_CR157","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/humu.20623","volume":"29","author":"BL Callewaert","year":"2008","unstructured":"Callewaert BL et al (2008) Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families. Hum Mutat 29(1):150\u2013158","journal-title":"Hum Mutat"},{"issue":"1","key":"8_CR158","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/jmedgenet-2011-100382","volume":"49","author":"IM van de Laar","year":"2012","unstructured":"van de Laar IM et al (2012) Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome. J Med Genet 49(1):47\u201357","journal-title":"J Med Genet"}],"container-title":["Advances in Experimental Medicine and Biology","Progress in Heritable Soft Connective Tissue Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-007-7893-1_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T15:48:41Z","timestamp":1746114521000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-94-007-7893-1_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,14]]},"ISBN":["9789400778924","9789400778931"],"references-count":158,"URL":"https:\/\/doi.org\/10.1007\/978-94-007-7893-1_8","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,14]]},"assertion":[{"value":"14 December 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}